4Schneider HPG. The view of the international menopause society on the women's health initiative. Climacteric, 2002,5:211-216
5Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med, 1999,340:1801-1811
6Gallagher PE, Li P, Lenhart JR, et al. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension, 1999,33:323-328
7Umeda M, Ichikawa S, Kanda T, et al. Hormone replacement therapy increase plasma of angiotensin Ⅱ in postmenopausal hypertensive women. Am J Hypertens, 2001, 14 (3) :206-211
8Imthurn B, Rosselli M, Jaeger AW, et al. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. JCE&M, 1997, 82:388-394
9Kawano H, Motoyama T, Hirai N, et al. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women. Am J Cardiol, 2001,87:238-240
10Sitruk-ware R. Progestins and cardiovascular risk markers. Steroids, 2000, 65:651-658
